Choosing the source of stem cells for allogeneic transplantation: no longer a peripheral issue.
Appelbaum
F R
FR
Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, WA, USA. fappelba@fhcrc.org
D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D006086:Graft vs Host Disease / Q000453:epidemiology; D020350:Graft vs Tumor Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D012008:Recurrence; D013154:Spleen / Q000473:pathology; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000637:transplantation; D014184:Transplantation, Homologous; D016896:Treatment Outcome